Page 21 - AN-4-3

Advanced Neurology Stem cell therapy in stroke treatment: Advances and prospects

84. Zheng H, Zhang B, Chhatbar PY, et al. Mesenchymal stem Cells Transl Med. 2018;7(7):521-529.
cell therapy in stroke: A systematic review of literature doi: 10.1002/sctm.18-0008
in pre-clinical and clinical research. Cell Transplant.
2018;27(12):1723-1730. 91. Negoro T, Okura H, Maehata M, et al. Trends in clinical
trials for stroke by cell therapy: Data mining ClinicalTrials.
doi: 10.1177/0963689718806846 gov and the ICTRP portal site. NPJ Regen Med. 2019;4(1):20.
85. de Celis-Ruiz E, Fuentes B, Alonso de Leciñana M, doi: 10.1038/s41536-019-0082-7
et al. Final results of allogeneic adipose tissue–derived
mesenchymal stem cells in acute ischemic stroke 92. Chumnanvej S, Chumnanvej S. Autologous bone-marrow
(AMASCIS): A phase II, randomized, double-blind, mononuclear stem cell therapy in patients with stroke:
placebo-controlled, single-center, pilot clinical trial. Cell A meta-analysis of comparative studies. Biomed Eng Online.
Transplant. 2022;31:09636897221083863. 2020;19:1-3.

doi: 10.1177/09636897221083863 doi: 10.1186/s12938-020-00819-7
86. Moll G, Ankrum JA, Olson SD, Nolta JA. Improved MSC 93. He JQ, Sussman ES, Steinberg GK. Revisiting stem cell-based
minimal criteria to maximize patient safety: A call to clinical trials for ischemic stroke. Front Aging Neurosci.
embrace tissue factor and hemocompatibility assessment of 2020;12:575990.
MSC products. Stem Cells Transl Med. 2022;11(1):2-13. doi: 10.3389/fnagi.2020.575990
doi: 10.1093/stcltm/szab005 94. Rikhtegar R, Yousefi M, Dolati S, et al. Stem cell‐based
87. Moniche F, Gonzalez A, Gonzalez-Marcos JR, et al. Intra- cell therapy for neuroprotection in stroke: A review. J Cell
arterial bone marrow mononuclear cells in ischemic stroke: Biochem. 2019;120(6):8849-8862.
A pilot clinical trial. Stroke. 2012;43(8):2242-2244. doi: 10.1002/jcb.28207
doi: 10.1161/STROKEAHA.112.659409 95. Mohan GV, Tirumandyam G, Vemulapalli HS, Vajje J,
88. Zhang G, Li Y, Reuss JL, et al. Stable intracerebral Asif H, Saleem F. Mesenchymal stem cell therapy for a
transplantation of neural stem cells for the treatment of Better Prognosis of Heart Failure: A systematic review and
paralysis due to ischemic stroke. Stem Cells Transl Med. Meta-analysis of Randomized controlled trials. Cureus.
2019;8(10):999-1007. 2023;15(8):e43037.
doi: 10.1002/sctm.18-0220 doi: 10.7759/cureus.43037
89. Prasad K, Sharma A, Garg A, et al. Intravenous autologous 96. Trounson A, Thakar RG, Lomax G, Gibbons D. Clinical
bone marrow mononuclear stem cell therapy for trials for stem cell therapies. BMC Med. 2011;9:1-7.
ischemic stroke: A multicentric, randomized trial. Stroke. doi: 10.1186/1741-7015-9-52
2014;45(12):3618-3624.
97. Fears R, Akutsu H, Alentajan-Aleta LT, et al. Inclusivity
doi: 10.1161/STROKEAHA.114.007028 and diversity: Integrating international perspectives
on stem cell challenges and potential. Stem Cell
90. Laskowitz DT, Bennett ER, Durham RJ, et al. Allogeneic
umbilical cord blood infusion for adults with ischemic Rep. 2021;16(8):1847-1852.
stroke: Clinical outcomes from a phase I safety study. Stem doi: 10.1016/j.stemcr.2021.07.003

Volume 4 Issue 3 (2025) 15 doi: 10.36922/an.5582